What is Corium?
Corium is a biopharmaceutical entity dedicated to the development and commercialization of neuroscience therapies. The company currently markets two FDA-approved products in the United States: ADLARITY and AZSTARYS. These therapies are designed to provide physicians with advanced treatment alternatives for neurological conditions. Corium has also established licensing agreements for the development and commercialization of these products in select international territories, indicating a global ambition for its neuroscience portfolio. The company's strategic focus on unmet needs within the neuroscience landscape positions it as a key player in advancing patient care.
How much funding has Corium raised?
Corium has raised a total of $556M across 2 funding rounds:
Stock Offering
$52M
Private Equity
$504M
Stock Issuance/Offering (2014): $52M, investors not publicly disclosed
Private Equity (2018): $504M led by Gurnet Point Capital
Key Investors in Corium
Gurnet Point Capital
Gurnet Point Capital is a healthcare fund founded by Ernesto Bertarelli and led by Chris Viehbacher, focusing on long-term capital investment and supporting companies across life sciences and medical technologies. They invest across all stages of product development through to commercialization.
What's next for Corium?
With the recent infusion of $504M in a major strategic investment, Corium is poised for accelerated growth and enhanced market penetration. This enterprise-level funding is expected to fuel further research and development initiatives, potentially expanding its pipeline of neuroscience therapies. The company may also leverage this capital to bolster its commercialization efforts for ADLARITY and AZSTARYS, both domestically and internationally, through its existing licensing agreements. Strategic partnerships and potential acquisitions could also be on the horizon as Corium solidifies its position in the competitive biopharmaceutical sector, aiming to deliver impactful solutions for neurological disorders.
See full Corium company page
